Sertraline versus fluoxetine in the treatment of major depression: A combined analysis of five double-blind comparator studies

International Clinical Psychopharmacology

Volumn 18, Issue 4, 2003, Pages 203-210

  Feiger, Alan D ^a   Flament, Martine F ^b   Boyer, Patrice ^c   Gillespie, John A ^d  

^a Feiger Health Research Center   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d PFIZER INC   (United States)

Author keywords

Anxiety; Depressive disorder; Fluoxetine; Meta analysis; Serotonin uptake inhibitors; Sertraline

Indexed keywords

FLUOXETINE; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; META ANALYSIS; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECEPTOR AFFINITY; REMISSION;

EID: 0038441913     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200307000-00002     Document Type: Article

References (19)

1. American Psychiatric Association (1993). Practice guideline for major depressive disorder in adults. Am J Psychiatry 150 (suppl 14):1-26.
2. Bondareff W, Alpert M, Friedhoff AJ, Richter EM, Clary CM, Batzar E (2000). Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry 157:729-736.
3. Boyer P, Danion JM, Bisserbe JC, Hotton JM, Troy S (1998). Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France. Pharmacoeconomics 13:157-169.
4. Breslow NE, Day NE (1980). Statistical Methods in Cancer Research, vol. I. The Analysis of Case-Control Studies. Lyons: IARC Scientific Publications.
5. Corruble E, Guelfi JD (1999). Is there a relationship between clinical efficacy and antidepressant dosage in major depression? Encephale 25:39-43.
6. Depression Guideline Panel (1993). Depression in Primary Care, vol. I. Detection and Diagnosis. Clinical Practice Guideline, Number 5. AHCPR Publication no. 93-0550. Rockville, MD: US Department of Health and Human Service, Public Health Service, Agency for Health Care Policy and Research.
7. Fawcett J, Barkin RL (1998). A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. J Clin Psychiatry 59:123-127.
8. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851-855.
9. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology. Washington, DC: National Institute of Mental Health, US Department of Health, Education, and Welfare; pp. 276-338.
10. Latimer PR, Ravindran AV, Bernatchez J-P, Fournier J-P, Goyer JA, Barrat K, Buttars J (1996). A six month comparison of toleration and efficacy of sertraline and fluoxetine treatment in major depression. Eur Neuropsychopharmacol 6 (suppl 3):124-132.
11. Murray CJ, Lopez AD (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349;1498-1504.
12. Newhouse PA, Krishnan KR, Doraiswamy PM, Richter EM, Batzar ED, Clary CM (2000). A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry 61:559-568.
13. Owens MJ, Knight DL, Nemeroff CB (2001). Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50:345-350.
14. Roose SP, Glassman AH, Attia E, Woodring S (1994). Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151:1735-1739.
15. Rudolph RL, Entsuah R, Chitra R (1998). A meta-analysis of the effects of venlafaxine on anxiety associated with depression. J Clin Psychopharmacol 18:136-144.
16. Sechter D, Troy S, Paternetti S, Boyer P (1999). A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. Eur Psychiatry 14:41-48.
17. Tedlow J, Fava M, Uebelacker L, Nierenberg AA, Alpert JE, Rosenbaum J (1998). Outcome definitions and predictors in depression. Psychother Psychosom 67:266-270.
18. Tollefson GD, Holman SL, Sayler ME, Potvin JH (1994). Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 55:50-59.
19. van Moffaert MM, de Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J (1995). A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Hum Psychopharmacol 10:393-405.